Endoscopic ultrasound (EUS)-guided pancreatic anti-tumoral therapy Jan. 05, 2021 Overview Show transcript Overview Michael J. Levy, M.D., a gastroenterologist at Mayo Clinic's campus in Rochester, Minnesota, discusses the use of EUS-guided pancreatic antitumoral therapy for the treatment of pancreatic masses. Dr. Levy addresses the safety, status, efficacy, and potential advantages and disadvantages associated with options available for local pancreatic ablation, including chemotherapy, alcohol injection and radiofrequency ablation. Receive Mayo Clinic news in your inbox. Sign up Related ContentArticle3 factors associated with improved outcomes for individuals with pancreatic ductal adenocarcinomaArticleEvaluating the safety and diagnostic accuracy of endoscopic fine-needle aspiration for detection of extravascular migratory metastases in the pancreas VID-20506258 Medical Professionals Endoscopic ultrasound (EUS)-guided pancreatic anti-tumoral therapy